Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Reports in Pharmaceutical Sciences
  4. Articles

  5. Evaluation of Cytotoxic and Apoptotic Effects of DT386–BR2: A Promising Anticancer Fusion Protein
  6. Crossref

Journal of Reports in Pharmaceutical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APCAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Crossref


1. Buforins: A Potential Antimicrobial Peptide Explored With Its Anticancer Efficacy‐A Review

- Surya Narayan Ratha Adhikari

- Jitendra Jena

- Sanjeeb Kumar Kar

- Alka Singh

- Biman Kumar Panigrahi

- Manoj Kumar Sarangi

2. Application of Antimicrobial Peptides in the Design and Production of Anticancer Agents

- Bahareh Vakili

- Ali Jahanian-Najafabadi

3. Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?

- Leon M. T. Dicks

- Wian Vermeulen

4. BR2, a Buforin Derived Cancer Specific Cell Penetrating Peptide for Targeted Delivering of Toxic Agents: a Review Article

- Fatemeh Sadeghi

- Marziyeh Kajbaf

- Fatemeh Shafiee

HomeInstructionsAPCAnnouncement of New Publisher

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.